Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Novel Approach to Cardiovascular Diseases: A Promising Probability of (Pro)Renin Receptor [(P)RR]

Author(s): Takashi Ando and Atsuhiro Ichihara

Volume 20, Issue 14, 2014

Page: [2371 - 2376] Pages: 6

DOI: 10.2174/13816128113199990472

Price: $65

Open Access Journals Promotions 2
Abstract

Inhibition of the renin-angiotensin system (RAS) has been shown to have beneficial effects in cardiovascular disease prognosis and therapy.Discovery of (pro)renin receptor [(P)RR] revealed that (P)RR upon binding to both renin or prorenin in their proenzyme inactive form made them enzymatically active, thus aiding the catalytic conversion of angiotensinogen (AGT) to angiotensin (Ang) I. This binding also transduces intracellular signal to the nucleus via various pathways. Our recent research elucidated the physiological roles of (P)RR in cell life, wherein it acts as an essential accessory protein of vacuolar H+-ATPase (V-ATPase) as well as an adaptor protein of Wnt signaling. The present review provides insights into a novel approach to cardiovascular diseases, which will open the gates to new therapeutic approaches for treating cardiovascular diseases.

Keywords: (Pro)renin receptor, vascuolar H+-ATPase, direct renin inhibitor.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy